Jan 4, 2023
Processa Pharmaceuticals (NASDAQ: PCSA), a diversified clinical-stage company developing products to improve survival and/or the quality of life for patients with unmet medical need conditions, today announced that its CEO Dr. David Young will present an update on Processa’s future therapeutic focus and strategy at the upcoming Biotech Showcase. The presentation is scheduled to begin at 10 a.m. PT on Jan. 11, 2023. Interested parties should visit https://ibn.fm/LcSFO to register for and access the webcast. In addition, the company’s management will be available for one-on-one meetings with potential investors and partners in San Francisco throughout the J.P. Morgan 41st Annual HealthCare Conference week. Meetings can be requested through the Biotech Showcase partnering platform or by contacting Processa directly at [email protected].
To view the full press release, visit https://ibn.fm/Z92Fb
About Processa Pharmaceuticals Inc.
The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options that improve survival and/or quality of life. The company uses its Regulatory Science Approach criteria when selecting and developing drugs to achieve high-value milestones effectively and efficiently. Current clinical pipeline programs include: Next Generation Capecitabine PCS6422 (metastatic colorectal cancer, breast cancer), PCS3117 (pancreatic and other cancers), PCS11T (small cell lung and other cancers), PCS12852 (gastroparesis, functional constipation), and PCS499 (ulcerative necrobiosis lipoidica). Members of the Processa development team have been involved with more than 30 approvals for indications in almost every division of the FDA (including drug products targeted to orphan disease conditions) and more than 100 FDA meetings throughout their careers. For more information, visit the company’s website at www.ProcessaPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork
The Heelers might be a fictional family, but many real families will also have been priced out of owning a home in the vast majority of Perth suburbs and forced into renting long-term.
The reality TV star faces domestic violence charges after he allegedly attacked his wife Snezana during a holiday in Noosa on Queensland’s Sunshine Coast.
CPC Central Committee holds press conference on plenary session
The billionaire’s regenerative farm and hospitality venture in the Southern Highlands is facing questions from council over its development approval.
Thousands of birds take to the skies over Yellow River Delta
The Australian sharemarket has opened higher after a volatile night on overseas markets.
Golden hues everywhere! Autumn at its finest!
No protester sets out expecting a friend to be arrested, injured or caught in a confrontation with the police. Yet when that happens, the reasons for returning to the streets can change. People may return not only because of the cause that first brought them out, but because they believe a friend has been treated unjustly. That is how anger becomes personal, and how a protest can move towards a dangerous cycle of action and reaction. This is the risk confronting France. The student protests...
[The content of this article has been produced by our advertising partner.] Global venture capital is surging in 2026, fuelled by concentrated investment in AI, digital infrastructure, robotics and other frontier technologies. At the same time, agentic AI, tokenisation, stable coins and programmable finance are accelerating the movement of capital across borders, giving rise to an emerging ‘agentic economy.’ Against this backdrop, CVCF 2026 aims to further energise and accelerate venture...
For commuters who have endured pink replacement buses for years, the opening of the final stretch between Sydenham and Bankstown could not come soon enough. Follow live.
The People’s Liberation Army (PLA) is distributing second-hand briefcases, salvaging screws and steel bars, and reusing holiday decorations to keep costs down as part of a thrift campaign emphasising growth through frugality. It forms part of a broader cost-cutting effort in the Chinese military under Beijing’s 15th five-year plan covering 2026 to 2030, which calls for building the armed forces through “diligence and thrift” and pursuing a path of “high efficiency, low cost and...
Ashley Paul Griffith has been charged with committing 202 child abuse offences over more than three years while he was employed at a Sydney childcare centre.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.